From the publishers of JADPRO

Biomarkers in NSCLC Resource Center

Advertisement

Emerging Biomarkers for Neoadjuvant Immune Checkpoint Inhibitors in Operable Non–Small Cell Lung Cancer

This article summarizes the initial results from the trials of neoadjuvant immune checkpoint inhibitors in patients with early-stage and locally advanced operable NSCLC and review the findings of studies investigating emerging biomarkers associated with those trials.

Translational Lung Cancer Research
Advertisement
News & Literature Highlights
Advertisement
Advertisement